Patrick Kwok‐Shing Ng

Author

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Jiexin Zhang, K. NG, K. Ng, Kwok-Shing Ng, Ng, Patrick, Ng, Patrick Kwok-Shing, P K S Ng, P. Ng, P.K.S. Ng, Patrick K. S. Ng

Publications

8.1K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Chinese University of Hong Kong Baylor College of Medicine Harvard University Oregon Health & Science University

About

Patrick Kwok‐Shing Ng is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	2.4K
2	Health Sciences	2	2	55
3	Natural Sciences	2	2	86
4	Public Health	1	1	23
5	Biology	1	1	49

Patrick Kwok‐Shing Ng

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Comprehensive Characterization of Cancer Driver Genes and Mutations Matthew H. Bailey, Collin Tokheim, Eduard Porta‐Pardo, Cell	2018	2.4K
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations Yiqun Zhang, Patrick Kwok‐Shing Ng, Melanie H. Kucherlapati, Cancer Cell Tumor BiologyCancer GenomicsPi3k/akt/mtor Pathway AlterationsTumor SuppressorSystems Biology	2017	646
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers Vivian Wai Yan Lui, Matthew L. Hedberg, Hua Li, Cancer Discovery Mtor/pi3k InhibitorPathologyFrequent MutationCancer BiologyPi3k Pathway	2013	575
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer Yumeng Wang, Xiaoyan Xu, Dejan Maglic, Cell Reports	2018	493
Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors Changmeng Cai, Sen Chen, Patrick Kwok‐Shing Ng, Cancer Research Tumor BiologyAndrogen ReceptorUrologyEndocrine-related CancerMedicine	2011	418
Systematic Functional Annotation of Somatic Mutations in Cancer Patrick Kwok‐Shing Ng, Jun Li, Kang Jin Jeong, Cancer Cell Somatic VariantCancer GenomicsSystematic Functional AnnotationCancer GeneticsSystems Biology	2018	347
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancers Chaoyang Sun, Yong Fang, Jun‐Jie Yin, Science Translational Medicine	2017	231
The draft genome, transcriptome, and microbiome of Dermatophagoides farinae reveal a broad spectrum of dust mite allergens Ting‐Fung Chan, Kunmei Ji, Aldrin Kay-Yuen Yim, Journal of Allergy and Clinical Immunology	2014	181
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer Vivian Wai Yan Lui, Noah D. Peyser, Patrick Kwok‐Shing Ng, Proceedings of the National Academy of Sciences	2014	102
Naturally Occurring Neomorphic PIK3R1 Mutations Activate the MAPK Pathway, Dictating Therapeutic Response to MAPK Pathway Inhibitors Lydia W.T. Cheung, Shuangxing Yu, Dong Zhang, Cancer Cell Signal TransductionMapk Pathway InhibitorsSignaling PathwayReceptor Tyrosine KinaseGenetics	2014	96

Page 1